Hai Zheng Pharmaceutical: Net profit will be 541 million yuan in 2025, a year-on-year decrease of 10.06%

Sea Trust Pharmaceuticals announced that its operating revenue in 2025 was 10.55 billion yuan, a year-on-year increase of 2.03%. The net profit attributable to the shareholders of the listed company was 541 million yuan, a year-on-year decrease of 10.06%. It is planned to distribute a cash dividend of 0.21 yuan per share to all shareholders, with a total cash dividend of 243 million yuan.